- Contractors
- Idt Biologika Gmbh
Idt Biologika Gmbh
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Idt Biologika Gmbh has 6 federal contracts of $100,000 or more active since October 2023, with $12.1M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.
- Contracts
- 6 since FY2024$12,148,183 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- National Institutes of Health$12.1M on 6 contracts
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- E14GD5J873N9Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2020 | $1,763,602 |
| FY2021 | $883,131 |
| FY2023 | $4,154,750 |
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Manufacture of Influenza Virus Human Challenge Material for Phase 1 and 2.National Institutes of Health · 75N93023F00001 | $4,154,750 | May 14, 2028in 17 months | Not stated |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| National Institutes of Health6 contracts | $12,148,183 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 6 contracts | $12,148,183 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| Maryland4 contracts | $5,269,733 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.
Get new notices like Idt Biologika Gmbh's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy